Posted On: 03/01/2014 9:57:49 AM
Post# of 63743
$DMPI new climber $1.44
Shares Outstanding 24,100,236 a/o Dec 04, 2013
Float 21,435,694 a/o Dec 04, 2013
Authorized Shares 200,000,000 a/o Dec 04, 2013
Par Value 0.001
DelMar Pharmaceuticals: Following The Former CEO Of Celgene On His Fight Against Brain Cancer
2/26/2014 8:35:00 AM - Seeking Alpha
DelMar Pharmaceuticals Provides Update on VAL-083 Glioblastoma Clinical Trial
2/26/2014 8:00:00 AM - PR Newswire
SeeThruEquity Initiates Research Coverage on DelMar Pharmaceuticals, Inc.
1/13/2014 9:00:00 AM - PR Newswire
Shares Outstanding 24,100,236 a/o Dec 04, 2013
Float 21,435,694 a/o Dec 04, 2013
Authorized Shares 200,000,000 a/o Dec 04, 2013
Par Value 0.001
DelMar Pharmaceuticals: Following The Former CEO Of Celgene On His Fight Against Brain Cancer
2/26/2014 8:35:00 AM - Seeking Alpha
DelMar Pharmaceuticals Provides Update on VAL-083 Glioblastoma Clinical Trial
2/26/2014 8:00:00 AM - PR Newswire
SeeThruEquity Initiates Research Coverage on DelMar Pharmaceuticals, Inc.
1/13/2014 9:00:00 AM - PR Newswire
(0)
(0)Scroll down for more posts ▼
